Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FOLFOXIRI Regimen”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01219920
What this trial is testing

FOLFOXIRI Compared With FOLFIRI for Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 244
Testing effectiveness (Phase 2)UnknownNCT03711240
What this trial is testing

The Efficacy of Bevacizumab Combined With m-FOLFOXIRI in Borderline Resectable Colorectal Liver Metastases

Who this might be right for
Colorectal Cancer
National Cheng-Kung University Hospital 40
Large-scale testing (Phase 3)Ended earlyNCT03678428
What this trial is testing

FUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM

Who this might be right for
Metastatic Colorectal CancerLiver Metastases
Sun Yat-sen University 92
Testing effectiveness (Phase 2)Study completedNCT02295930
What this trial is testing

Induction Chemoterapy With Folfoxiri Plus Cetuxumab in Unresectable Colorectal Cancer Patient

Who this might be right for
Metastatic Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 143
Testing effectiveness (Phase 2)UnknownNCT04097444
What this trial is testing

CAPOXIRI+Bevacizumab vs. FOLFOXIRI+Bevacizumab for mCRC

Who this might be right for
Metastatic Colorectal Cancer
Chugai Pharmaceutical 112
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07070713
What this trial is testing

Efficacy and Safety of FOLFOX+Cetuximab vs. FOLFOXIRI+Bevacizumab Both With QL1706 in First-Line Treatment of Left-Sided mCRC

Who this might be right for
Metastatic Colorectal Cancer With Left-sided Primary TumorImmunotherapy
Fujian Cancer Hospital 44
Testing effectiveness (Phase 2)UnknownNCT06148402
What this trial is testing

Fruquintinib Plus Camrelizumab and Capecitabine as Salvage Therapy After Progression on FOLFOXIRI-based First-line Treatment in Patients With Unresectable/Metastatic Colorectal Cancer

Who this might be right for
Unresectable/Metastatic Colorectal Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 30
Testing effectiveness (Phase 2)UnknownNCT04832776
What this trial is testing

FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver Metastases

Who this might be right for
Liver Metastasis Colon Cancer
Fudan University 160
Testing effectiveness (Phase 2)Study completedNCT02705300
What this trial is testing

Side Effects to FOLFOXIRI + Tocotrienol/Placebo as First Line Treatment of Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Vejle Hospital 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT03391843
What this trial is testing

Neoadjuvant Chemotherapy Combined With Cetuximab for EGFR Wild Type Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer Stage III
RenJi Hospital 100
Testing effectiveness (Phase 2)Study completedNCT04513951
What this trial is testing

AVELUMAB and CETUXIMAB and mFOLFOXIRI as Initial Therapy for Unresectable Metastatic Colorectal Cancer Patients

Who this might be right for
Metastatic Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 62
Testing effectiveness (Phase 2)UnknownNCT05839470
What this trial is testing

Cadonilimab Plus FOLFOXIRI and Bevacizumab as First Line Therapy for Metastatic MSS Colorectal Cancer

Who this might be right for
Colorectal Cancer
Fujian Cancer Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT01765582
What this trial is testing

Sequential and Concurrent FOLFOXIRI/Bevacizumab Regimens Versus FOLFOX/Bevacizumab in First-Line Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Hoffmann-La Roche 280
Testing effectiveness (Phase 2)Active Not RecruitingNCT05253846
What this trial is testing

Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29

Who this might be right for
Locally Advanced Rectal Cancer
Gruppo Oncologico del Nord-Ovest 63
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06099951
What this trial is testing

Total Neoadjuvant Treatment for pMMR Locally Advanced Low Rectal Cancer: Anti-PD-1 Antibody With FOLFOXIRI and Preoperative Radiation Therapy

Who this might be right for
Colorectal Cancer
Sun Yat-sen University 53
Testing effectiveness (Phase 2)Ended earlyNCT02175654
What this trial is testing

Regorafenib as Single Agent in Patients With Metastatic Colorectal Cancer (mCRC) With Any RAS or BRAF Mutation Previously Treated With FOLFOXIRI Plus Bevacizumab

Who this might be right for
Colorectal NeoplasmsMetastatic Disease
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 15
Testing effectiveness (Phase 2)WithdrawnNCT03222089
What this trial is testing

Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRC

Who this might be right for
Metastatic Colorectal Cancer
Fujian Cancer Hospital
Large-scale testing (Phase 3)Looking for participantsNCT05194878
What this trial is testing

Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers

Who this might be right for
Colon Cancer Stage IIColon Cancer Stage III
Sun Yat-sen University 840
Large-scale testing (Phase 3)Looking for participantsNCT03671252
What this trial is testing

Prospectively Randomized Control Clinical Trial of FOLFOXIRI Preoperative Chemotherapy Alone on Rectal Cancer in Local Advance Comparing to Oral Capecitabine Combined With Long-term Radiation

Who this might be right for
Rectal Cancer
Sun Yat-sen University 776
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07817888
What this trial is testing

MFOLFOXIRI Plus Bevacizumab for Organ Preservation in Locally Advanced Rectal Cancer

Who this might be right for
Phase 2 Study
Sixth Affiliated Hospital, Sun Yat-sen University 119
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation